The Future is Bright for Stem Cell Treatments
Considering the many emerging research studies on possible cord blood and cord tissue stem cell use, the future of stem cell treatments is very bright. Only the surface has been scratched when it comes to discovering the potential of these cells to treat diseases and disorders. New technologies that allow for the expansion of cord blood cells means that effective autologous therapy will be achievable well into adulthood. Additionally, research has shown that cord blood stem cells can also be effectively used for regeneration or repair, of non-hematopoietic tissues, such as the repair of joint damage through cartilage regeneration. Studies have also demonstrated that these cells are effective at modulating/reducing inflammation, and in the treatment of neurological disorders (ie. ALS, Alzheimer’s Disease, Stroke) that can occur later in life. Keeping up with the latest news inspires hope in the future.
Umbilical cord blood stem cells kill cancer quicker than adult cells
New research results suggest that stem cells in umbilical cord blood are better at destroying leukemia cells than adult stem cells. Umbilical cord blood is increasingly being used instead of bone marrow transplants because the risk of rejection is lower with the immature cells. While cord blood stem cells haven’t had the “training” that adult stem cells have had, “it seems they can pitch straight in without practice,” says research team member Paul Veys of Great Ormond Street Hospital for Children in London. “The implication is that using cord blood may be a better choice to mop up leukemia,” he says.
Children to receive umbilical cord blood in world first cerebral palsy trial
Australian children with cerebral palsy will be infused with umbilical cord blood, in a world first medical trial at the Royal Children's Hospital in Melbourne. The study hopes to find that stem cells from cord blood can repair brain injury that leads to cerebral palsy.
A Promising Trial Uses Blood Derived Stem Cells to Treat Multiple Sclerosis
A stem cell treatment routinely used for bone and blood cancers is showing promise at reversing the effects of multiple sclerosis (MS). The treatment, known as autologous hematopoietic stem cell transplant (HSCT), uses chemotherapy to break down the patient's faulty immune system. Stem cells are then harvested and re-infused into the patient to 'reboot' their immune system. Within two weeks, new red and white blood cells start to grow. One of the primary source of hematopoietic stem cells is umbilical cord blood.
Stem Cells Offer New Ways to Repair Joints
The normal tendon, when we repair it, heals with scar tissue. That’s where the stem cells come in. Instead of scar tissue taking over, the hope is that the stem cells, which have the ability to differentiate, will help generate more normal anatomy.
First Clinical Trial Using Stem Cells to Treat Alzheimer’s Disease
A new clinical trial at the University of Miami Miller School of Medicine will be the first in the U.S. to focus on using mesenchymal stem cells (MSCs) to treat Alzheimer’s disease. MSCs are increasingly being utilized in regenerative medicine for a wide range of conditions including heart and kidney disease, ALS, wound healing and autoimmune diseases. The umbilical cord is a rich source of mesenchymal stem cells.
Congress Approves Stem Cell Act Reauthorization
Legislation reauthorizing the Stem Cell Therapeutic and Research Act has been overwhelmingly passed by both the U.S. Senate and House of Representatives. The bill authorizes $23 million per year for the next five years for cord blood inventory growth and diversity. The Cord Blood Association, together with the National Marrow Donor Program (NMDP), worked tirelessly with members of Congress this year and testified in support of the legislation that totals $115 million for five years for the National Cord Blood Inventory (NCBI) and $150 million in that same period for blood and marrow transplant programs through the C.W. Bill Young Transplantation Program.
Patented Stem Cell Therapy to Treat Heart Failure Uses Cord Blood Stem Cells
Creative Medical Health Inc. was issued the patent titled, “Combination Therapy of Cardiovascular Disease.” The patent covers the use of adult stem cells such as cord blood and mesenchymal stem cells in combination with modulation of oxidative stress in treatment of heart failure. Additionally, the patent covers in-treatment assessment of oxidative stress so as to give doctors ability to personalize the treatment protocol to the particular needs of the patient.
Upbeat Update from Duke on Stem Cell Autism Trial
This week at the World Stem Cell Summit, Dr. Joanne Kurtzberg, Pediatric Bone Marrow Transplant Specialist at Duke University Medicine, gave an encouraging update on the cord blood stem cell trial to treat autism.
Umbilical Stem Cells Help Retinal Neurons Grow
Stem cell therapy has shown immense potential for the treatment of neurological disorders. Now, research has shown that stem cells found in human umbilical cord tissue could one day be used to treat degenerative eye diseases.
Blood of world's oldest woman hints at limits of life
Researchers have now examined her blood and other tissues to see how they were affected by age. What they found suggests, as we could perhaps expect, that our lifespan might ultimately be limited by the capacity for stem cells to keep replenishing tissues day in day out.